¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ XXXQAY-,C  
AH:0h X6+  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© *0_Q0SeE,o  
#W4 "^#2  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© F><ficT  
x X.{(er  
1.Co-stimulators (or co-stimulating molecules) 7s Gf_`Z  
WfYG#!}x  
2.NK-kB vb9C& #  
7}pg7EF3z  
3.Immunoglobulin superfamily HK VtO%&  
c IPOI'3d  
4.antigen-presenting cell (APC) ;R$2+9  
X,}(MW  
5.death domain aYc^ 9*7  
K{ntl-D&y  
6.CCR and CXCR eYevj[c;  
,E"n7*6mr  
7.Lectin (or mitogen) BKYyc6iE  
}hcY5E-n  
8.Clusters of differentiation, CD) $weC '-n@  
o/& IT(v  
9.B7 family m^w{:\p  
ZKM@U?PK  
10.Cytotoxic T lymphocyte, CTL) (O& HCT|  
[GcW*v  
11.IL-15 and IL-15 receptor (IL-15R) by\Sq}  
)"7z'ar  
12.MHC restriction l hST%3Ld  
+=sw&DH  
13.Affinity-chromatography 9Q'[>P=1  
Q 9E.AN   
14.Cyctosprin A, CsA +k[w)7Q  
Eu%E2A|`I  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) hE<Sm*HU  
9SJSUv:@  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© U*,\UF  
G,<l}(tEG  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 S)/548=`  
Ul}<@d9: B  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ f .$*9Fkw  
%jHe_8=o  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ H!>>|6OPF  
mI]gDL1  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© [B+:)i  
y ~su1wUp  
ÃâÒßѧרҵ£º *z.rOY= 8  
X5)(,036  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Et0)6^-v  
cBv"d ~  
Ïû»¯ÄÚ¿Æ£º .2s^8gO  
tGzp= PyA  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ! h92dH  
7[!dm_  
ѪҺ²¡Ñ§×¨Òµ£º 29m$ S7[  
3s67)n  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»